Home » Pharma Blog Watch
Pharma Blog Watch
June 14, 2006
Plan
B and Lester Crawford (Eye On FDA)
The Minneapolis Star Tribune
and Associated Press have reported that "Lester Crawford is stating that
there was no attempt to disallow Plan B's switch from RX to OTC, but rather that
he delayed the switch with the idea that the agency would have by now acted, he
said in testimony," writes blogger Mark Senak. In his entry, Senak discusses
the questions raised by Crawford's actions.
ED
Drug Sales Slipping Why, and What Can be Done? (Pharma Marketing Blog)
Manufacturers
of erectile dysfunction (ED) drugs have retooled their marketing campaigns in
the wake of a sales slump. In his entry, blogger John Mack writes about the factors
contributing to this slump.
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct